Ao Jiao

450 citations
27 papers · 310 indexed · h-index 12

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Pancreatic function and diabetes
    • Intestinal Malrotation and Obstruction Disorders

Papers in

Ao Jiao

26 papers receiving 307 citations

Peers

Ao Jiao
Comparison fields: 5 of 66
  • Cancer Research 37
  • Surgery 101
  • Molecular Biology 147
  • Hepatology 16
  • Physiology 45
Replace Anneleen Remmerie with:
Anneleen Remmerie Belgium
Anna Walentinsson Sweden
Laurie Erickson United States
Yuda Wei China
Yuto Shiode Japan
Tatjana Josefs United States
Longwei Zhao China
Xi Hong China
Fengyan Deng United States
Ao Jiao relative to Anneleen Remmerie Belgium Anneleen Remmerie's profile →
Citations per field
00.5×1.5×
Anneleen Remmerie · 1×
Citations per year

Countries citing papers authored by Ao Jiao

Since Specialization
Citations

This map shows the geographic impact of Ao Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ao Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ao Jiao more than expected).

Fields of papers citing papers by Ao Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ao Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ao Jiao. The network helps show where Ao Jiao may publish in the future.

Co-authors

The 25 scholars most cited alongside Ao Jiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ao Jiao Line = papers co-authored together Ao Jiao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20253
3 20251
4 20242
5 20241
6 20247
7 20240
8 202212
9 202220
10 20218
11 202010
12 201911
13 201917
14 201832
15 201826
16 201814
17 20189
18 201728
19 201714
20 201619

About Ao Jiao

Ao Jiao is a scholar working on Biotechnology, Hepatology, Physiology, Cancer Research and Molecular Biology, having authored 27 papers that have together received 310 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Pancreatic function and diabetes (4 papers), Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (2 papers), Insect-Plant Interactions and Control (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (37 citations), Surgery (101 citations), Molecular Biology (147 citations), Hepatology (16 citations) and Physiology (45 citations). Ao Jiao has collaborated with scholars based in China, South Korea and Netherlands. Frequent co-authors include Jialin Zhang, Chengshuo Zhang, Ning Sun, Baomin Chen, Wu Lv, Bochao Zhao, Xiaohang Li, Francel Verstappen, Iris F. Kappers and Jun He. Their work appears in journals such as Frontiers in Immunology, BioMed Research International, Medicine, BMC Cancer and Canadian Journal of Physiology and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026